Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
63.50
-0.50 (-0.78%)
Apr 24, 2025, 1:05 PM CST
-2.01%
Market Cap 3.19B
Revenue (ttm) n/a
Net Income (ttm) -118.89M
Shares Out 49.80M
EPS (ttm) -2.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,000
Average Volume 19,775
Open 63.20
Previous Close 64.00
Day's Range 63.00 - 63.50
52-Week Range 57.00 - 70.50
Beta -0.09
RSI 46.67
Earnings Date Apr 18, 2025

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.